C1S and infectious disease: While mutation of C1s is associated with rare genetic diseases and susceptibility to infections and autoimmune disorders, ongoing studies have indicated that the aberrant activation of C1s contributes to the development of autoimmune and infectious diseases and cancer, and serves as an informative biomarker and therapeutic target (Figure 1-2).